Hemostasis Today

October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
Oct 10, 2026, 07:59

Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity

Leila Caroline Souza Reis, Medical Residency in Internal Medicine at the University of São Paulo School of Medicine, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in RPTH, adding:

“Our systematic review and meta-analysis on enoxaparin dosing for venous thromboembolism prophylaxis in adults with obesity was presented at the 2026 Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Paris, France.

We found that enoxaparin 60 mg was associated with a higher likelihood of achieving prophylactic anti-Xa targets compared with 40 mg, although evidence regarding clinical outcomes remains limited.

An international research collaboration developed with the support of Meta-Analysis Academy.”

Title: PB1714 Enoxaparin 40 mg Versus 60 mg for Venous Thromboembolism Prophylaxis in Adults with Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Authors: Leila Caroline Souza Reis, Anthony Josué Rojas Anchía, Laís Helena Navarro e Lima, Stephanie Assunção Valini, Charlotte Meagher, Rodrigo Moreira e Lima, Júlio Cesar de Oliveira

Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity

Stay updated with Hemostasis Today.